Gilead Sciences' TROP2-targeting drug Trodelvy is already used as a third-line treatment for PD-L1-positive triple-negative breast cancer (TNBC), but could be heading for use in previously untreated ...
Chris McCarthy shows up for an early-morning interview wearing raspberry-colored scrubs. Later he’ll head to one of Kaiser Permanente’s Bay Area hospitals to watch nurses at work. McCarthy, a KP ...
When we read stories, watch films or TV shows, look at pictures or play video games, we use lots of different skills to work out what is happening. One of these skills is called inference. Inferring ...
Abstract: Traditional instantaneous overcurrent protection schemes encounter significant challenges in power lines, particularly when line impedances are low, resulting in minimal differences in fault ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results